Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (NASDAQ:SNGX)

2.15
Delayed Data
As of Jun 23
 +0.05 / +2.38%
Today’s Change
1.90
Today|||52-Week Range
8.50
-4.44%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close2.10
Today’s open2.15
Day’s range2.10 - 2.20
Volume29,050
Average volume (3 months)470,948
Market cap$12.2M
Dividend yield--
Data as of 3:59pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+55.33%
Earnings growth (this year)--
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+19.16%
P/E ratioNM
Price/Sales0.77
Price/Book1.59

Competitors

 Today’s
change
Today’s
% change
XTNTXtant Medical Holdin...+0.06+9.16%
PZRXPhaseRx Inc+0.04+4.30%
IGCIndia Globalization ...+0.01+1.25%
RXIIRxi Pharmaceuticals ...-0.01-1.70%
Data as of 4:02pm ET, 06/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$10.4M
Annual profit (last year)-$3.2M
Net profit margin-31.06%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer &
Senior Vice President
Karen R. Krumeich
Corporate headquarters
Princeton, New Jersey

Forecasts